Industry News - Tag: Procter & Gamble

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

P&G faces USD1.9 bn headwind as costs rise
Premium

3 August 2021

Procter & Gamble (P&G) is expecting a USD1.9 billion headwind from rising commodity and freight costs in the 12 months ended 30 June 2022. Chief financial officer Andre Schulten says the company is considering additional price increases on top of those already announced.

Read the full story

COVID-19 restrictions dent P&G’s OTC sales
Premium

22 April 2021

Procter & Gamble (P&G) said worldwide sales at its Personal Health Care business had decreased by "mid-single-digits" on an organic basis in the three months ended 31 March 2021. The company has announced plans to introduce significant price increases for its Baby Care, Feminine Care and Adult Incon...

Read the full story

Industry in brief | P&G, AFT, Sanofi

12 January 2021

Procter & Gamble (P&G) has abandoned its proposed acquisition of Billie, AFT Pharmaceuticals’ Maxigesic pain reliever has been launched in Canada as Combogesic, and Sanofi has revealed the name and chief of its proposed active pharmaceutical ingredients (API) company.

Read the full story